6 results about "Vitamin k" patented technology

This invention belongs to the field of microbial technology, specifically disclosing a probiotic composition and its application. The probiotic composition provided by this invention includes at least two of the following: prebiotics, vitamin K, and zinc, as well as *Bifidobacterium longum* subsp. infantis i18. The probiotic composition provided by this invention can not only effectively promote the growth and development of premature mice, but also optimize the intestinal flora structure and promote intestinal development in premature infants by reducing the abundance of harmful bacteria and increasing the relative abundance of beneficial bacteria; simultaneously, it can downregulate the levels of pro-inflammatory factors TNF-α and IL-6, reducing intestinal inflammation and lowering the risk of necrotizing enterocolitis in premature infants. This invention can be applied to the preparation of products that improve the intestinal flora of premature infants, promote their growth, or prevent intestinal inflammation.

The present invention aims to provide an epidermal barrier function improving agent and an aromatic hydrocarbon receptor activator containing Artemisia princeps extract and / or vitamin K as active ingredients. [Solution] The present invention provides an epidermal barrier function improving agent and an aromatic hydrocarbon receptor activator containing Artemisia princeps extract and / or vitamin K as active ingredients.

The invention relates to a cosmetic and / or pharmaceutical composition for preventing or reducing hair loss of a mammal due to stress and for use in the treatment of a hair growth disease or hair growth disorder exacerbated by stress.

The application relates to a CePO4@RuO2@Cu-MOF heteronano-wire and a preparation method thereof and application thereof in selective oxidation synthesis of vitamin K intermediates, and belongs to the technical field of nano functional materials and catalysis. The CePO4@RuO2@Cu-MOF heteronano-wire is a one-dimensional ternary structure, the one-dimensional CePO4 nano-wire is used as a core base material, the middle layer is RuO2 nano active sites in-situ heterogeneously grown, and the outer layer is a Cu-MOF porous shell layer in-situ grown; a continuous and firm hetero-interface is formed among the three phases. The material obtained by the application exhibits super-high product selectivity, excellent catalytic activity and super-long cycle stability in the reaction of catalyzing selective oxidation of 2-methylnaphthalene to prepare a vitamin K key intermediate through the channel limiting effect and interface electronic coupling effect of the outer layer Cu-MOF.

A preparation method for a vitamin K1 injection package, and a vitamin K1 injection package. The preparation method comprises filling, nitrogen flushing, stoppering and rod screwing; in the nitrogen flushing step, sterile nitrogen is introduced into a glass cartridge (1) to reduce oxygen content inside the glass cartridge (1) to 2.0% or less; in the stoppering step, the glass cartridge (1) is evacuated, thereby drawing a plunger (2) into the glass cartridge (1), and the headspace volume is controlled to 0.1-0.2 ml.

The present application relates to topical formulations comprising Compound-Ior its free base, and a second active agent selected from nicotinic acid, nicotinamide, and vitamin K, and a combination thereof, for treating ocular neovascularization. The present application also relates to pharmaceutical compositions comprising particles of Compound-I or its free base, and suspension formulations comprising the particle compositions of Compound-I or its free base.